Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies

Published:2021-10-08 Issue:23 Volume:81 Page:6029-6043
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Szydłowski Maciej^ORCID,Garbicz Filip^ORCID,Jabłońska Ewa,Górniak Patryk,Komar Dorota,Pyrzyńska Beata,Bojarczuk Kamil^ORCID,Prochorec-Sobieszek Monika,Szumera-Ciećkiewicz Anna^ORCID,Rymkiewicz Grzegorz^ORCID,Cybulska Magdalena,Statkiewicz Małgorzata,Gajewska Marta,Mikula Michał,Gołas Aniela,Domagała Joanna,Winiarska Magdalena,Graczyk-Jarzynka Agnieszka^ORCID,Białopiotrowicz Emilia,Polak Anna,Barankiewicz Joanna,Puła Bartosz,Pawlak Michał,Nowis Dominika^ORCID,Golab Jakub,Tomirotti Andrea M.,Brzózka Krzysztof,Pacheco-Blanco Mariana,Kupcova Kristyna,Green Michael R.,Havranek Ondrej,Chapuy Bjoern^ORCID,Juszczyński Przemysław

Funder

Foundation for Polish Science

Polish National Science Centre

iONCO grant

Operational Programme Innovative Economy

IT infrastructure of Science

The Czech Science Foundation

PRIMUS/17/MED/9

UNCE/MED/016

Progress Q26

Ministry of Education Youth and Sports of the Czech Republic

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer progression via deubiquitylation of MYC;Oncogene;2024-07-05

2. Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes;Targeted Oncology;2024-04-21

3. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome‐scale CRISPR‐Cas9 screening in myeloma cells;British Journal of Haematology;2024-03-10

4. A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1;Annals of Hematology;2024-03-01

5. PIM3 Kinase: A Promising Novel Target in Solid Cancers;Cancers;2024-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3